Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peicheng Lin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Nano Letters|March 27, 2023
Dielectric Metasurface for Synchronously Spiral Phase Contrast and Bright-Field ImagingYanzeng Zhang, Peicheng Lin, Pengcheng Huo, et al.
Nature Communications|April 29, 2025
Monolithic silicon carbide metasurfaces for engineering arbitrary 3D perfect vector vortex beamsMingze Liu, Peicheng Lin, Pengcheng Huo, et al.
Nature Communications|October 19, 2024
Broadband and parallel multiple-order optical spatial differentiation enabled by Bessel vortex modulated metalensPengcheng Huo, Le Tan, Yaqi Jin, et al.
Scientific Reports|August 12, 2025
Melanoma GPA as a novel prognostic scoring model based on initial brain metastasis velocityYibin Zeng, Feifei Lin, Hui Li, et al.
Physical Review Letters|January 15, 2021
Independent Amplitude Control of Arbitrary Orthogonal States of Polarization via Dielectric MetasurfacesQingbin Fan, Mingze Liu, Cheng Zhang, et al.
Nature Communications|November 7, 2023
Disordered metasurface enabled single-shot full-Stokes polarization imaging leveraging weak dichroismQingbin Fan, Weizhu Xu, Xuemei Hu, et al.
Annals of Medicine|July 9, 2026
Randomized phase-II trial of surufatinib plus FOLFOX/FOLFIRI versus FOLFOXIRI as second-line therapy for metastatic colorectal cancerLiyu Su, Peicheng Lin, Yi Yin, et al.
Nature Communications|April 9, 2024
Observation of spatiotemporal optical vortices enabled by symmetry-breaking slanted nanogratingPengcheng Huo, Wei Chen, Zixuan Zhang, et al.
Frontiers in Oncology|September 26, 2022
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancerShen Zhao, Liyu Su, Yigui Chen, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Nano Letters|March 27, 2023
Dielectric Metasurface for Synchronously Spiral Phase Contrast and Bright-Field ImagingYanzeng Zhang, Peicheng Lin, Pengcheng Huo, et al.
Nature Communications|April 29, 2025
Monolithic silicon carbide metasurfaces for engineering arbitrary 3D perfect vector vortex beamsMingze Liu, Peicheng Lin, Pengcheng Huo, et al.
Nature Communications|October 19, 2024
Broadband and parallel multiple-order optical spatial differentiation enabled by Bessel vortex modulated metalensPengcheng Huo, Le Tan, Yaqi Jin, et al.
Scientific Reports|August 12, 2025
Melanoma GPA as a novel prognostic scoring model based on initial brain metastasis velocityYibin Zeng, Feifei Lin, Hui Li, et al.
Physical Review Letters|January 15, 2021
Independent Amplitude Control of Arbitrary Orthogonal States of Polarization via Dielectric MetasurfacesQingbin Fan, Mingze Liu, Cheng Zhang, et al.
Nature Communications|November 7, 2023
Disordered metasurface enabled single-shot full-Stokes polarization imaging leveraging weak dichroismQingbin Fan, Weizhu Xu, Xuemei Hu, et al.
Annals of Medicine|July 9, 2026
Randomized phase-II trial of surufatinib plus FOLFOX/FOLFIRI versus FOLFOXIRI as second-line therapy for metastatic colorectal cancerLiyu Su, Peicheng Lin, Yi Yin, et al.
Nature Communications|April 9, 2024
Observation of spatiotemporal optical vortices enabled by symmetry-breaking slanted nanogratingPengcheng Huo, Wei Chen, Zixuan Zhang, et al.
Frontiers in Oncology|September 26, 2022
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancerShen Zhao, Liyu Su, Yigui Chen, et al.
Pageof 2